Latest Breaking News On - Harvey cushing neuro oncology laboratories - Page 1 : comparemela.com

BostonGene Announces Publication in Nature

BostonGene Announces Publication in Nature
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Nathan fowlerErin oreillyAntonio chioccaBostongene corporationDepartment of neurosurgeryHarvey cushing neuro oncology laboratoriesChief medical officer

BostonGene Announces Publication in Nature

BostonGene Announces Publication in Nature
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Antonio chioccaNathan fowlerDepartment of neurosurgeryBostongene corporationHarvey cushing neuro oncology laboratoriesChief medical officer

New approach for delivering medication across the blood-brain barrier to treat brain tumors

Researchers have demonstrated in mice a new approach for delivering medication across the blood-brain barrier to treat tumors that cause aggressive, lethal brain cancer.

National cheng kung universityTainan municipalityBruxelles capitaleSean lawlerBradley penteluteJimenez maciasJorgel jimenez maciasEmily hendersonNational institute of environmental health sciencesNational cancer instituteNational institutes of healthWarren alpert medical school legorreta cancer centerMassachusetts institute of technologyLab diagnostics automationHarvard medical schoolLab diagnostics automation industry

Activation of the STING pathway could help make glioblastoma multiforme more susceptible to immunotherapy

Immunotherapy has revolutionized treatment for many forms of cancer, but glioblastoma multiforme (GBM), the most common and deadly form of brain cancer, has remained untouched.

Bruxelles capitaleE antonio chioccaSean lawlerGilles bergerEmily hendersonDepartment of neurosurgeryUniversity of brusselsWyss instituteDana farber cancer instituteBrown universityBrigham department of neurosurgeryHarvey cushing neuro oncology laboratoriesAntonio chiocca

Codagenix Appoints Johanna Kaufmann, Ph D , Executive Vice President, Oncology to Lead Customization of Oncolytic Viruses for Solid Tumors

/PRNewswire/ Codagenix Inc., a clinical-stage biotechnology company developing prophylactic vaccines and oncolytic virus therapies for cancer, today.

United statesBaden wübergUnited kingdomJohanna bennett ingrid mezoJohanna kaufmannRobert colemanHelmholtz university groupEckard wimmer at stony brook universityHarvard medical schoolTesaro inc in walthamNational academy of scienceGerman cancer research centerDepartment of neurosurgeryPrnewswire codagenix incAutomation vaccine development at genocea biosciencesCodagenix inc